Citations (157)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (11)
Priyanka Kannan, Hadeefa Begum A.Madhana Priya N.Thirumal Kumar D.Gnansambandan Ramanathan, Rajalakshmanan Eswaramoorthy & Magesh Ramasamy. (2023) Unravelling the Relacatib activity against the CTSK proteins causing pycnodysostosis: a molecular docking and dynamics approach. Journal of Biomolecular Structure and Dynamics 0:0, pages 1-12.
Read now
Read now
Jakub Benýšek, Michal Buša, Petra Rubešová, Jindřich Fanfrlík, Martin Lepšík, Jiří Brynda, Zuzana Matoušková, Ulrike Bartz, Martin Horn, Michael Gütschow & Michael Mareš. (2022) Highly potent inhibitors of cathepsin K with a differently positioned cyanohydrazide warhead: structural analysis of binding mode to mature and zymogen-like enzymes. Journal of Enzyme Inhibition and Medicinal Chemistry 37:1, pages 515-526.
Read now
Read now
Fernanda R. Rocho, Vinícius Bonatto, Rafael F. Lameiro, Jerônimo Lameira, Andrei Leitão & Carlos A. Montanari. (2022) A patent review on cathepsin K inhibitors to treat osteoporosis (2011 – 2021). Expert Opinion on Therapeutic Patents 32:5, pages 561-573.
Read now
Read now
Isaac O. Donkor. (2020) An update on the therapeutic potential of calpain inhibitors: a patent review. Expert Opinion on Therapeutic Patents 30:9, pages 659-675.
Read now
Read now
C. Pitchumani Violet Mary, R. Shankar & S. Vijayakumar. (2018) Theoretical studies on the interaction between the nitrile-based inhibitors and the catalytic triad of Cathepsin K. Journal of Biomolecular Structure and Dynamics 36:3, pages 634-655.
Read now
Read now
Melisa Bunderson-Schelvan, Andrij Holian & Raymond F. Hamilton$suffix/text()$suffix/text(). (2017) Engineered nanomaterial-induced lysosomal membrane permeabilization and anti-cathepsin agents. Journal of Toxicology and Environmental Health, Part B 20:4, pages 230-248.
Read now
Read now
Dieter Brömme, Preety Panwar & Serap Turan. (2016) Cathepsin K osteoporosis trials, pycnodysostosis and mouse deficiency models: Commonalities and differences. Expert Opinion on Drug Discovery 11:5, pages 457-472.
Read now
Read now
Xianglian Yuan, Yonggang Liu, Xin Hua, Xiaoxia Deng, Peijiao Sun, Chunmei Yu, Liping Chen, Shenye Yu, Siguo Liu & Hai Pang. (2015) Myricetin ameliorates the symptoms of collagen-induced arthritis in mice by inhibiting cathepsin K activity. Immunopharmacology and Immunotoxicology 37:6, pages 513-519.
Read now
Read now
Miranda K Boggild, Olga Gajic-Veljanoski, Heather McDonald-Blumer, Rowena Ridout, Lianne Tile, Robert Josse & Angela M Cheung. (2015) Odanacatib for the treatment of osteoporosis. Expert Opinion on Pharmacotherapy 16:11, pages 1717-1726.
Read now
Read now
Kong Wah Ng. (2012) Potential role of odanacatib in the treatment of osteoporosis. Clinical Interventions in Aging 7, pages 235-247.
Read now
Read now
Jac Wijkmans & Jan Gossen. (2011) Inhibitors of cathepsin K: a patent review (2004 – 2010). Expert Opinion on Therapeutic Patents 21:10, pages 1611-1629.
Read now
Read now
Articles from other publishers (146)
Kajal Chakraborty. 2024. Cartilage Tissue and Knee Joint Biomechanics. Cartilage Tissue and Knee Joint Biomechanics
651
680
.
Shiva Shankar Jha. (2023) Biologics: Teriparatide and Newer Anabolics. Indian Journal of Orthopaedics.
Crossref
Crossref
Bridgette Hartley, Wesam Bassiouni, Richard Schulz & Olivier Julien. (2023) The roles of intracellular proteolysis in cardiac ischemia–reperfusion injury. Basic Research in Cardiology 118:1.
Crossref
Crossref
Alexis David, Thibault Chazeirat, Ahlame Saidi, Gilles Lalmanach & Fabien Lecaille. (2023) The Interplay of Glycosaminoglycans and Cysteine Cathepsins in Mucopolysaccharidosis. Biomedicines 11:3, pages 810.
Crossref
Crossref
Emanuela Senjor, Janko Kos & Milica Perišić Nanut. (2023) Cysteine Cathepsins as Therapeutic Targets in Immune Regulation and Immune Disorders. Biomedicines 11:2, pages 476.
Crossref
Crossref
Monika Biasizzo, Urban Javoršek, Eva Vidak, Miki Zarić & Boris Turk. (2022) Cysteine cathepsins: A long and winding road towards clinics. Molecular Aspects of Medicine 88, pages 101150.
Crossref
Crossref
Fabien Lecaille, Thibault Chazeirat, Ahlame Saidi & Gilles Lalmanach. (2022) Cathepsin V: Molecular characteristics and significance in health and disease. Molecular Aspects of Medicine 88, pages 101086.
Crossref
Crossref
David G.P. van IJzendoorn, Magdalena Matusiak, Gregory W. Charville, Geert Spierenburg, Sushama Varma, Deana R.C. Colburg, Michiel A.J. van de Sande, Kirsten van Langevelde, David G. Mohler, Kristen N. Ganjoo, Nam Q. Bui, Raffi S. Avedian, Judith V.M.G. Bovée, Robert Steffner, Robert B. West & Matt van de Rijn. (2022) Interactions in CSF1-Driven Tenosynovial Giant Cell Tumors. Clinical Cancer Research 28:22, pages 4934-4946.
Crossref
Crossref
Olja Mijanović, Aleksandra Jakovleva, Ana Branković, Kristina Zdravkova, Milena Pualic, Tatiana A. Belozerskaya, Angelina I. Nikitkina, Alessandro Parodi & Andrey A. ZamyatninJr.Jr.. (2022) Cathepsin K in Pathological Conditions and New Therapeutic and Diagnostic Perspectives. International Journal of Molecular Sciences 23:22, pages 13762.
Crossref
Crossref
Yihe Jia, Ke Wang, Huifang Wang, Botao Zhang, Kan Yang, Zhilan Zhang, Haijuan Dong & Jinxin Wang. (2022) Discovery of selective covalent cathepsin K inhibitors containing novel 4-cyanopyrimidine warhead based on quantum chemical calculations and binding mode analysis. Bioorganic & Medicinal Chemistry 74, pages 117053.
Crossref
Crossref
Wei Deng, YanBo Huang, HaiShang Li, ChiWei Chen, YueWei Lin, Min Wang, HuaSheng Huang, Teng Liu, QiuLi Qin, Yang Shao, YongChao Tang, Kai Yuan, JinYong Ding, LiangLiang Xu, YongXian Li & ShunCong Zhang. (2022) Dehydromiltirone inhibits osteoclast differentiation in RAW264.7 and bone marrow macrophages by modulating MAPK and NF-κB activity. Frontiers in Pharmacology 13.
Crossref
Crossref
Abirami Raja, Govind Pratap Singh, Sana A. Fadil, Sameh S. Elhady, Fadia S. Youssef & Mohamed L. Ashour. (2022) Prophylactic Anti-Osteoporotic Effect of Matricaria chamomilla L. Flower Using Steroid-Induced Osteoporosis in Rat Model and Molecular Modelling Approaches. Antioxidants 11:7, pages 1316.
Crossref
Crossref
Wiktoria Strasenburg, Jakub Jóźwicki, Justyna Durślewicz, Błażej Kuffel, Martyna Parol Kulczyk, Adam Kowalewski, Dariusz Grzanka, Tomasz Drewa & Jan Adamowicz. (2022) Tumor Cell-Induced Platelet Aggregation as an Emerging Therapeutic Target for Cancer Therapy. Frontiers in Oncology 12.
Crossref
Crossref
Elena V. Tchetina, Galina A. Markova, Azamat M. Satybaldyev & Aleksandr M. Lila. (2022) Downregulation of Tumour Necrosis Factor α Gene Expression in Peripheral Blood Mononuclear Cells Cultured in the Presence of Tofacitinib Prior to Therapy Is Associated with Clinical Remission in Patients with Rheumatoid Arthritis. Current Issues in Molecular Biology 44:5, pages 1941-1949.
Crossref
Crossref
Nicola C. FosterNicole M. HallAlicia J. El Haj. (2022) Two-Dimensional and Three-Dimensional Cartilage Model Platforms for Drug Evaluation and High-Throughput Screening Assays. Tissue Engineering Part B: Reviews 28:2, pages 421-436.
Crossref
Crossref
Siripat Chaichit, Pathomwat Wongrattanakamon, Busaban Sirithunyalug, Piyarat Nimmanpipug & Supat Jiranusornkul. (2022) Multitarget-Based Virtual Screening for Identification of Herbal Substances toward Potential Osteoclastic Targets. Applied Sciences 12:5, pages 2621.
Crossref
Crossref
Christian Horst Tonk, Sarah Hani Shoushrah, Patrick Babczyk, Basma El Khaldi-Hansen, Margit Schulze, Monika Herten & Edda Tobiasch. (2022) Therapeutic Treatments for Osteoporosis—Which Combination of Pills Is the Best among the Bad?. International Journal of Molecular Sciences 23:3, pages 1393.
Crossref
Crossref
Tapan Behl, Swati Chadha, Aayush Sehgal, Sukhbir Singh, Neelam Sharma, Rajwinder Kaur, Saurabh Bhatia, Ahmed Al-Harrasi, Sridevi Chigurupati, Ahmed Alhowail & Simona Bungau. (2022) Exploring the role of cathepsin in rheumatoid arthritis. Saudi Journal of Biological Sciences 29:1, pages 402-410.
Crossref
Crossref
Syed Ali Raza Naqvi, Tauqir A. Sherazi, Sohail Anjum Shahzad, Muhammad Rizwan Javed, Sana Nadeem, Muhammad Imran & Rashid Rasheed. 2022. Biochemistry of Drug Metabolizing Enzymes. Biochemistry of Drug Metabolizing Enzymes
191
208
.
Zhiguo Wang & Baofeng YangZhiguo Wang & Baofeng Yang. 2022. Polypharmacology. Polypharmacology
535
592
.
Renee T. Ormsby & Julia F. Charles. 2022. Early Osteoarthritis. Early Osteoarthritis
147
169
.
Stella Hernandes Maganhi, Ignez Caracelli, Julio Zukerman-Schpector, Rodrigo L.O.R. Cunha, Mauricio Angel Veja-Teijido & Edward R.T. Tiekink. (2021) Crystal structures and docking studies in cathepsin S of bioactive 1,3‐diphenyl‐4‐(trichloro‐λ4‐tellanyl)but‐2‐en‐1‐one derivatives. Journal of Molecular Structure 1244, pages 130935.
Crossref
Crossref
Avinash Soundararajan, Sachin Anil Ghag, Sai Supriya Vuda, Ting Wang & Padmanabhan Paranji Pattabiraman. (2021) Cathepsin K Regulates Intraocular Pressure by Modulating Extracellular Matrix Remodeling and Actin-Bundling in the Trabecular Meshwork Outflow Pathway. Cells 10:11, pages 2864.
Crossref
Crossref
Rutusmita Mishra, Neeladrisingha Das, Ritu Varshney, Kriti Juneja, Debabrata Sircar & Partha Roy. (2021) Betel leaf extract and its major component hydroxychavicol promote osteogenesis and alleviate glucocorticoid-induced osteoporosis in rats. Food & Function 12:14, pages 6603-6625.
Crossref
Crossref
Patrycja Ledwoń, Anna Maria Papini, Paolo Rovero & Rafal Latajka. (2021) Peptides and Peptidomimetics as Inhibitors of Enzymes Involved in Fibrillar Collagen Degradation. Materials 14:12, pages 3217.
Crossref
Crossref
Yaongamphi Vashum, Amuthavalli Kottaiswamy, Tholcopiyan Loganathan, Fathima B. Sheriff & Shila Samuel. (2021) Anti-carcinogenic Effect of Cathepsin K Inhibitor, Odanacatib with a Low Dose of Cisplatin Against Human Breast Carcinoma MCF-7 and MDA-MB231 Cells. Current Cancer Therapy Reviews 17:2, pages 159-169.
Crossref
Crossref
Siripat Chaichit, Takuto Sato, Huiqing Yu, Yu-ki Tanaka, Yasumitsu Ogra, Takamasa Mizoguchi & Motoyuki Itoh. (2021) Evaluation of Dexamethasone-Induced Osteoporosis In Vivo Using Zebrafish Scales. Pharmaceuticals 14:6, pages 536.
Crossref
Crossref
Shunichi Oka, Xiaoyan Li, Chieko Taguchi, Chen Wang, Nitesh Tewari, Kazumune Arikawa, Yi Liu & Ujjal K. Bhawal. (2021) Treatment with 50 μM Sodium Fluoride Suppresses Aging-Induced Alveolar Bone Resorption in Mice. Journal of Hard Tissue Biology 30:3, pages 225-230.
Crossref
Crossref
Malkiet Kaur, Manju Nagpal & Manjinder Singh. (2020) Osteoblast-n-Osteoclast: Making Headway to Osteoporosis Treatment. Current Drug Targets 21:16, pages 1640-1651.
Crossref
Crossref
Ryan Brown, Sridesh Nath, Alnardo Lora, Ghassan Samaha, Ziyad Elgamal, Ryan Kaiser, Clifford Taggart, Sinéad Weldon & Patrick Geraghty. (2020) Cathepsin S: investigating an old player in lung disease pathogenesis, comorbidities, and potential therapeutics. Respiratory Research 21:1.
Crossref
Crossref
Alaa Al-Hashimi, Vaishnavi Venugopalan, Maren Rehders, Naphannop Sereesongsaeng, Zeynep Hein, Sebastian Springer, Ekkehard Weber, Dagmar Führer, Matthew S. Bogyo, Christopher J. Scott, Roberta E. Burden & Klaudia Brix. (2020) Procathepsin V Is Secreted in a TSH Regulated Manner from Human Thyroid Epithelial Cells and Is Accessible to an Activity-Based Probe. International Journal of Molecular Sciences 21:23, pages 9140.
Crossref
Crossref
Gen-Cheng Gong, Sheng-Ren Song, Xin Xu, Qun Luo, Qian Han, Jian-Xing He & Jin Su. (2020) Serpina3n is closely associated with fibrotic procession and knockdown ameliorates bleomycin-induced pulmonary fibrosis. Biochemical and Biophysical Research Communications 532:4, pages 598-604.
Crossref
Crossref
Taynara L. Silva, Deborah A. dos Santos, Hugo C.R. de Jesus, Dieter Brömme, João B. Fernandes, Marcio W. Paixão, Arlene G. Corrêa & Paulo C. Vieira. (2020) Green asymmetric synthesis of epoxypeptidomimetics and evaluation as human cathepsin K inhibitors. Bioorganic & Medicinal Chemistry 28:15, pages 115597.
Crossref
Crossref
Rongchen Dai, Zeting Wu, Hang Yin Chu, Jun Lu, Aiping Lyu, Jin Liu & Ge Zhang. (2020) Cathepsin K: The Action in and Beyond Bone. Frontiers in Cell and Developmental Biology 8.
Crossref
Crossref
Meghan C. Ferrall-Fairbanks, Chris A. Kieslich & Manu O. Platt. (2020) Reassessing enzyme kinetics: Considering protease-as-substrate interactions in proteolytic networks. Proceedings of the National Academy of Sciences 117:6, pages 3307-3318.
Crossref
Crossref
Enas A. Fouad-Elhady, Hadeer A. Aglan, Rasha E. Hassan, Hanaa H. Ahmed & Gilane M. Sabry. (2020) Modulation of bone turnover aberration: A target for management of primary osteoporosis in experimental rat model. Heliyon 6:2, pages e03341.
Crossref
Crossref
Fabien Lecaille, Thibault Chazeirat, Krzysztof K. Bojarski, Justine Renault, Ahlame Saidi, V. Gangadhara N.V. Prasad, Sergey Samsonov & Gilles Lalmanach. (2020) Rat cathepsin K: Enzymatic specificity and regulation of its collagenolytic activity. Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics 1868:2, pages 140318.
Crossref
Crossref
Hai Le, Umesh Metkar, Afshin E. Razi & Stuart H. Hershman. 2020. Vertebral Compression Fractures in Osteoporotic and Pathologic Bone. Vertebral Compression Fractures in Osteoporotic and Pathologic Bone
221
227
.
Ahlame Saidi, Mariana Kasabova, Lise Vanderlynden, Mylène Wartenberg, Ghania Hounana Kara-Ali, Daniel Marc, Fabien Lecaille & Gilles Lalmanach. (2019) Curcumin inhibits the TGF-β1-dependent differentiation of lung fibroblasts via PPARγ-driven upregulation of cathepsins B and L. Scientific Reports 9:1.
Crossref
Crossref
Francesco Cogo, Rich Williams, Roberta E. Burden & Christopher J. Scott. (2019) Application of nanotechnology to target and exploit tumour associated proteases. Biochimie 166, pages 112-131.
Crossref
Crossref
Tanja Jakoš, Anja Pišlar, Anahid Jewett & Janko Kos. (2019) Cysteine Cathepsins in Tumor-Associated Immune Cells. Frontiers in Immunology 10.
Crossref
Crossref
Keriann M. Backus, Jian Cao & Sean M. Maddox. (2019) Opportunities and challenges for the development of covalent chemical immunomodulators. Bioorganic & Medicinal Chemistry 27:15, pages 3421-3439.
Crossref
Crossref
Nejc Petek, Bogdan Štefane, Marko Novinec & Jurij Svete. (2019) Synthesis and biological evaluation of 7-(aminoalkyl)pyrazolo[1,5-a]pyrimidine derivatives as cathepsin K inhibitors. Bioorganic Chemistry 84, pages 226-238.
Crossref
Crossref
Yacoubou Abdoul Razak Mahaman, Fang Huang, Henok Kessete Afewerky, Tanko Mahamane Salissou Maibouge, Bishwajit Ghose & Xiaochuan Wang. (2018) Involvement of calpain in the neuropathogenesis of Alzheimer’s disease. Medicinal Research Reviews 39:2, pages 608-630.
Crossref
Crossref
Son Tung Ngo, Khanh B. Vu, Le Minh Bui & Van V. Vu. (2019) Effective Estimation of Ligand-Binding Affinity Using Biased Sampling Method. ACS Omega 4:2, pages 3887-3893.
Crossref
Crossref
Elma Mons, Ineke D. C. Jansen, Jure Loboda, Bjorn R. van Doodewaerd, Jill Hermans, Martijn Verdoes, Constant A. A. van Boeckel, Peter A. van Veelen, Boris Turk, Dusan Turk & Huib Ovaa. (2019) The Alkyne Moiety as a Latent Electrophile in Irreversible Covalent Small Molecule Inhibitors of Cathepsin K. Journal of the American Chemical Society 141:8, pages 3507-3514.
Crossref
Crossref
Shanmuganathan Pandiarajan, Shila Samuel, Tholcopiyan Loganathan, ShyamSundar Jaganathan, Thiagarajan Krishnamurthi, Radhakrishnan Sarangapani, VinodKumar Anandan & Ramasubramanian Venkatachalam. (2019) Pila globosa snail extract inhibits osteoclast differentiation via downregulation of nuclear factor κB and nuclear factor of activated T-Cells c1 signaling pathways. Pharmacognosy Magazine 15:64, pages 298.
Crossref
Crossref
Radha Madhyastha, Harishkumar Madhyastha, Yutthana Pengjam, Queen Intan Nurrahmah, Yuichi Nakajima & Masugi Maruyama. (2018) The pivotal role of microRNA-21 in osteoclastogenesis inhibition by anthracycline glycoside aloin. Journal of Natural Medicines 73:1, pages 59-66.
Crossref
Crossref
E. V. ChetinaG. A. Markova. (2018) Patient stratification and choice of therapy based on blood gene expression profiles in rheumatoid arthritis. Modern Rheumatology Journal 12:4, pages 16-22.
Crossref
Crossref
Sumana Roy, Sudeshna Das Chakraborty & Sampa Biswas. (2018) Not all pycnodysostosis‐related mutants of human cathepsin K are inactive – crystal structure and biochemical studies of an active mutant I249T. The FEBS Journal 285:22, pages 4265-4280.
Crossref
Crossref
Harshika Awasthi, Dayanandan Mani, Divya Singh & Atul Gupta. (2018) The underlying pathophysiology and therapeutic approaches for osteoporosis. Medicinal Research Reviews 38:6, pages 2024-2057.
Crossref
Crossref
Awen Menou, JanWillem Duitman & Bruno Crestani. (2018) The impaired proteases and anti-proteases balance in Idiopathic Pulmonary Fibrosis. Matrix Biology 68-69, pages 382-403.
Crossref
Crossref
Raphaël De Ridder, Eveline Boudin, Geert Mortier & Wim Van Hul. (2018) Human Genetics of Sclerosing Bone Disorders. Current Osteoporosis Reports 16:3, pages 256-268.
Crossref
Crossref
Preety Panwar, Simon Law, Andrew Jamroz, Pouya Azizi, Dongwei Zhang, Marco Ciufolini & Dieter Brömme. (2018) Tanshinones that selectively block the collagenase activity of cathepsin K provide a novel class of ectosteric antiresorptive agents for bone. British Journal of Pharmacology 175:6, pages 902-923.
Crossref
Crossref
Richard Lonsdale & Richard A. Ward. (2018) Structure-based design of targeted covalent inhibitors. Chemical Society Reviews 47:11, pages 3816-3830.
Crossref
Crossref
Preety Panwar, Georgina S. Butler, Andrew Jamroz, Pouya Azizi, Christopher M. Overall & Dieter Brömme. (2018) Aging-associated modifications of collagen affect its degradation by matrix metalloproteinases. Matrix Biology 65, pages 30-44.
Crossref
Crossref
Sherry Niessen, Melissa M. Dix, Sabrina Barbas, Zachary E. Potter, Shuyan Lu, Oleg Brodsky, Simon Planken, Douglas Behenna, Chau Almaden, Ketan S. Gajiwala, Kevin Ryan, RoseAnn Ferre, Michael R. Lazear, Matthew M. Hayward, John C. Kath & Benjamin F. Cravatt. (2017) Proteome-wide Map of Targets of T790M-EGFR-Directed Covalent Inhibitors. Cell Chemical Biology 24:11, pages 1388-1400.e7.
Crossref
Crossref
Simon Law, Preety Panwar, Jody Li, Adeleke H. Aguda, Andrew Jamroz, Rafael V. C. Guido & Dieter Brömme. (2017) A composite docking approach for the identification and characterization of ectosteric inhibitors of cathepsin K. PLOS ONE 12:10, pages e0186869.
Crossref
Crossref
Lovro Kramer, Dušan Turk & Boris Turk. (2017) The Future of Cysteine Cathepsins in Disease Management. Trends in Pharmacological Sciences 38:10, pages 873-898.
Crossref
Crossref
Andreas Kling, Katja Jantos, Helmut Mack, Wilfried Hornberger, Karla Drescher, Volker Nimmrich, Ana Relo, Karsten Wicke, Charles W. Hutchins, Yanbin Lao, Kennan Marsh & Achim Moeller. (2017)
Discovery of Novel and Highly Selective Inhibitors of Calpain for the Treatment of Alzheimer’s Disease: 2-(3-Phenyl-1
H
-pyrazol-1-yl)-nicotinamides
. Journal of Medicinal Chemistry 60:16, pages 7123-7138.
Crossref
Crossref
Hong Li, Chenyue Ding, Zhi-liang Ding, Mingfa Ling, Ting Wang, Wei Wang & Boxian Huang. (2017) 17β-Oestradiol promotes differentiation of human embryonic stem cells into dopamine neurons via cross-talk between insulin-like growth factors-1 and oestrogen receptor β. Journal of Cellular and Molecular Medicine 21:8, pages 1605-1618.
Crossref
Crossref
Antonio Cabal, Donald S. Williams, Richa Y. Jayakar, Jingru Zhang, Swanand Sardesai & Le T. Duong. (2017) Long-term treatment with odanacatib maintains normal trabecular biomechanical properties in ovariectomized adult monkeys as demonstrated by micro-CT-based finite element analysis. Bone Reports 6, pages 26-33.
Crossref
Crossref
Simon Law, Pierre-Marie Andrault, Adeleke H. Aguda, Nham T. Nguyen, Natasha Kruglyak, Gary D. Brayer & Dieter Brömme. (2017) Identification of mouse cathepsin K structural elements that regulate the potency of odanacatib. Biochemical Journal 474:5, pages 851-864.
Crossref
Crossref
Natasha Kruglyak, David E. Williams, Henry Chen, Simon Law, Jadwiga Kaleta, Ivan Villanueva, Julian E. Davies, Raymond J. Andersen & Dieter Brömme. (2017) Leupeptazin, a highly modified tripeptide isolated from cultures of a Streptomyces sp. inhibits cathepsin K. Bioorganic & Medicinal Chemistry Letters 27:6, pages 1397-1400.
Crossref
Crossref
Clifford Taggart, Marcus A. Mall, Gilles Lalmanach, Didier Cataldo, Andreas Ludwig, Sabina Janciauskiene, Nicole Heath, Silke Meiners, Christopher M. Overall, Carsten Schultz, Boris Turk & Keren S. Borensztajn. (2017) Protean proteases: at the cutting edge of lung diseases. European Respiratory Journal 49:2, pages 1501200.
Crossref
Crossref
Hadi Abou-El-Hassan, Fares Sukhon, Edwyn Jeremy Assaf, Hisham Bahmad, Hussein Abou-Abbass, Hussam Jourdi & Firas H. Kobeissy. 2017. Neuroproteomics. Neuroproteomics
65
99
.
A. Dolzhenko, T. Richter & S. Sagalovsky. (2016) VASCULAR CALCIFICATION, ATHEROSCLEROSIS AND BONE LOSS (OSTEOPOROSIS): NEW PATHOPHYSIOLOGICAL MECHANISMS AND FUTURE PERSPECTIVES FOR PHARMACOLOGICAL THERAPY. Almanac of Clinical Medicine 44:4, pages 513-534.
Crossref
Crossref
Zuo-Cheng Qiu, Xiao-Li Dong, Yi Dai, Gao-Keng Xiao, Xin-Luan Wang, Ka-Chun Wong, Man-Sau Wong & Xin-Sheng Yao. (2016) Discovery of a New Class of Cathepsin K Inhibitors in Rhizoma Drynariae as Potential Candidates for the Treatment of Osteoporosis. International Journal of Molecular Sciences 17:12, pages 2116.
Crossref
Crossref
Sheila Siqueira Andrade, Iuri Estrada Gouvea, Mariana Cristina C. Silva, Elo?sa Dognani Castro, Cl?udia A. A. de Paula, Debora Okamoto, Lilian Oliveira, Giovani Bravin Peres, Tatiana Ottaiano, Gil Facina, Afonso Celso Pinto Naz?rio, Antonio Hugo J. F. M. Campos, Edgar Julian Paredes-Gamero, Maria Juliano, Ismael D. C. G. da Silva, Maria Luiza V. Oliva & Manoel J. B. C. Gir?o. (2016) Cathepsin K induces platelet dysfunction and affects cell signaling in breast cancer - molecularly distinct behavior of cathepsin K in breast cancer. BMC Cancer 16:1.
Crossref
Crossref
Tooba Naz Shamsi, Romana Parveen & Sadaf Fatima. (2016) Characterization, biomedical and agricultural applications of protease inhibitors: A review. International Journal of Biological Macromolecules 91, pages 1120-1133.
Crossref
Crossref
Elżbieta Plebanek, Florian Chevrier, Vincent Roy, Thibault Garenne, Fabien Lecaille, Dawid Warszycki, Andrzej J. Bojarski, Gilles Lalmanach & Luigi A. Agrofoglio. (2016) Straightforward synthesis of 2,4,6-trisubstituted 1,3,5-triazine compounds targeting cysteine cathepsins K and S. European Journal of Medicinal Chemistry 121, pages 12-20.
Crossref
Crossref
Catera L. Wilder, Charlene Walton, Valencia Watson, Fermin A.A. Stewart, Jade Johnson, Shelly R. Peyton, Christine K. Payne, Valerie Odero-Marah & Manu O. Platt. (2016) Differential cathepsin responses to inhibitor-induced feedback: E-64 and cystatin C elevate active cathepsin S and suppress active cathepsin L in breast cancer cells. The International Journal of Biochemistry & Cell Biology 79, pages 199-208.
Crossref
Crossref
Kakoli Mukherjee & Naibedya Chattopadhyay. (2016) Pharmacological inhibition of cathepsin K: A promising novel approach for postmenopausal osteoporosis therapy. Biochemical Pharmacology 117, pages 10-19.
Crossref
Crossref
Anna Cline-Smith, Jesse Gibbs, Elena Shashkova, Zachary S. Buchwald & Rajeev Aurora. (2016) Pulsed low-dose RANKL as a potential therapeutic for postmenopausal osteoporosis. JCI Insight 1:13.
Crossref
Crossref
Kristi M. Porter, Friedrich A. Wieser, Catera L. Wilder, Neil Sidell & Manu O. Platt. (2016) Cathepsin Protease Inhibition Reduces Endometriosis Lesion Establishment. Reproductive Sciences 23:5, pages 623-629.
Crossref
Crossref
Shengfu Piao & Ravi K. Amaravadi. (2015) Targeting the lysosome in cancer. Annals of the New York Academy of Sciences 1371:1, pages 45-54.
Crossref
Crossref
Le T. Duong, Albert T. Leung & Bente Langdahl. (2015) Cathepsin K Inhibition: A New Mechanism for the Treatment of Osteoporosis. Calcified Tissue International 98:4, pages 381-397.
Crossref
Crossref
Matej Vizovišek, Robert Vidmar, Marko Fonović & Boris Turk. (2016) Current trends and challenges in proteomic identification of protease substrates. Biochimie 122, pages 77-87.
Crossref
Crossref
Manu O. Platt & W. Andrew Shockey. (2016) Endothelial cells and cathepsins: Biochemical and biomechanical regulation. Biochimie 122, pages 314-323.
Crossref
Crossref
Lidice González, Rafael E. Sánchez, Laritza Rojas, Isel Pascual, Rossana García-Fernández, María A. Chávez & Christian Betzel. (2016) Screening of Protease Inhibitory Activity in Aqueous Extracts of Marine Invertebrates from Cuban Coast. American Journal of Analytical Chemistry 07:04, pages 319-331.
Crossref
Crossref
Manti Guha, Satish Srinivasan, Alexander Koenigstein, Mone Zaidi & Narayan G. Avadhani. (2015) Enhanced osteoclastogenesis by mitochondrial retrograde signaling through transcriptional activation of the cathepsin K gene. Annals of the New York Academy of Sciences 1364:1, pages 52-61.
Crossref
Crossref
Preety Panwar, Kent Søe, Rafael VC Guido, Renata V C Bueno, Jean-Marie Delaisse & Dieter Brömme. (2016) A novel approach to inhibit bone resorption: exosite inhibitors against cathepsin K. British Journal of Pharmacology 173:2, pages 396-410.
Crossref
Crossref
Andrés Felipe Posada, Hernán Darío Aguirre, Julio Cesar García Casallas, Jhon Darío Lodoño Patiño & Rafael Valle Oñate. (2016) New therapies in osteoporosis. Revista Colombiana de Reumatología (English Edition) 23:1, pages 34-43.
Crossref
Crossref
Andrés Felipe Posada, Hernán Darío Aguirre, Julio Cesar García Casallas, Jhon Darío Lodoño Patiño & Rafael Valle Oñate. (2016) Nuevas terapias en osteoporosis. Revista Colombiana de Reumatología 23:1, pages 34-43.
Crossref
Crossref
Urška Verbovšek, Cornelis J.F. Van Noorden & Tamara T. Lah. (2015) Complexity of cancer protease biology: Cathepsin K expression and function in cancer progression. Seminars in Cancer Biology 35, pages 71-84.
Crossref
Crossref
Thomas C Schultz, Jonathan P Valenzano, Jessica L Verzella & Elena M Umland. (2015) Odanacatib: An Emerging Novel Treatment Alternative for Postmenopausal Osteoporosis. Women's Health 11:6, pages 805-814.
Crossref
Crossref
Polyzois Makras, Sideris Delaroudis & Athanasios D. Anastasilakis. (2015) Novel therapies for osteoporosis. Metabolism 64:10, pages 1199-1214.
Crossref
Crossref
Jure Borišek, Matej Vizovišek, Piotr Sosnowski, Boris Turk, Dušan Turk, Barbara Mohar & Marjana Novič. (2015)
Development of
N
-(Functionalized benzoyl)-homocycloleucyl-glycinonitriles as Potent Cathepsin K Inhibitors
. Journal of Medicinal Chemistry 58:17, pages 6928-6937.
Crossref
Crossref
Keon-Young Park, Gande Li & Manu O. Platt. (2015) Monocyte-derived macrophage assisted breast cancer cell invasion as a personalized, predictive metric to score metastatic risk. Scientific Reports 5:1.
Crossref
Crossref
Song P. Seto, Akia N. Parks, Yongzhi Qiu, Louis J. Soslowsky, Spero Karas, Manu O. Platt & Johnna S. Temenoff. (2015) Cathepsins in Rotator Cuff Tendinopathy: Identification in Human Chronic Tears and Temporal Induction in a Rat Model. Annals of Biomedical Engineering 43:9, pages 2036-2046.
Crossref
Crossref
Klaudia Brix, Joseph McInnes, Alaa Al-Hashimi, Maren Rehders, Tripti Tamhane & Mads H. Haugen. (2014) Proteolysis mediated by cysteine cathepsins and legumain—recent advances and cell biological challenges. Protoplasma 252:3, pages 755-774.
Crossref
Crossref
C. Wilczynski, S. Samarasinghe, M. A. Emanuele, N. Emanuele, L. Shah & A. Mazhari. (2015) Cathepsins K and S: Role in Bone, Adipocytes, and Glucose Regulation. Clinical Reviews in Bone and Mineral Metabolism 13:1, pages 2-10.
Crossref
Crossref
Graeme F. Wilkinson & Kevin Pritchard. (2015) In Vitro Screening for Drug Repositioning. SLAS Discovery 20:2, pages 167-179.
Crossref
Crossref
Marion Gamsj?ger & Heinrich Resch. (2015) Cathepsin K-Inhibitoren: pr?klinische und klinische DatenCathepsin K antagonists: preclinical and clinical data. Wiener Medizinische Wochenschrift 165:3-4, pages 65-70.
Crossref
Crossref
Vidhu Sharma, Preety Panwar, Anthony J. O’DonoghueHaoran Cui, Rafael V. C. Guido, Charles S. CraikDieter Brömme. (2014) Structural requirements for the collagenase and elastase activity of cathepsin K and its selective inhibition by an exosite inhibitor. Biochemical Journal 465:1, pages 163-173.
Crossref
Crossref
Adeleke H. Aguda, Preety Panwar, Xin Du, Nham T. Nguyen, Gary D. Brayer & Dieter Brömme. (2014) Structural basis of collagen fiber degradation by cathepsin K. Proceedings of the National Academy of Sciences 111:49, pages 17474-17479.
Crossref
Crossref
Tao Li, Shou-Mian Wu, Zhi-Yuan Xu & Sheng Ou-Yang. (2014) Rabbiteye blueberry prevents osteoporosis in ovariectomized rats. Journal of Orthopaedic Surgery and Research 9:1.
Crossref
Crossref
Urška Verbovšek, Helena Motaln, Ana Rotter, Nadia A. Atai, Kristina Gruden, Cornelis J. F. Van Noorden & Tamara T. Lah. (2014) Expression Analysis of All Protease Genes Reveals Cathepsin K to Be Overexpressed in Glioblastoma. PLoS ONE 9:10, pages e111819.
Crossref
Crossref
Yubo Guo, Yu Li, Liming Xue, Richele P. Severino, Sihua Gao, Jianzhao Niu, Lu-Ping Qin, Dongwei Zhang & Dieter Brömme. (2014) Salvia miltiorrhiza: An ancient Chinese herbal medicine as a source for anti-osteoporotic drugs. Journal of Ethnopharmacology 155:3, pages 1401-1416.
Crossref
Crossref
Ali Mohammad Alizadeh, Sadaf Shiri & Sadaf Farsinejad. (2014) Metastasis review: from bench to bedside. Tumor Biology 35:9, pages 8483-8523.
Crossref
Crossref
Kumar Saurav, Wenjun Zhang, Subhasish Saha, Haibo Zhang, Sumei Li, Qingbo Zhang, Zhengchao Wu, Guangtao Zhang, Yiguang Zhu & Gaurav Verma. (2014) In silico molecular docking, preclinical evaluation of spiroindimicins A-D, lynamicin A and D isolated from deep marine sea derived Streptomyces sp. SCSIO 03032. Interdisciplinary Sciences: Computational Life Sciences 6:3, pages 187-196.
Crossref
Crossref
Marko Fonovi?Boris Turk. (2014) Cysteine cathepsins and extracellular matrix degradation. Biochimica et Biophysica Acta (BBA) - General Subjects 1840:8, pages 2560-2570.
Crossref
Crossref
Tomasz Respondek, Rajgopal Sharma, Mackenzie K. Herroon, Robert N. Garner, Jessica D. Knoll, Eric Cueny, Claudia Turro, Izabela Podgorski & Jeremy J. Kodanko. (2014) Inhibition of Cathepsin Activity in a Cell‐Based Assay by a Light‐Activated Ruthenium Compound. ChemMedChem 9:6, pages 1306-1315.
Crossref
Crossref
Nikhilesh Arya, Archana Y. Jagdale, Tushar A. Patil, Shradha S. Yeramwar, Sidharam S. Holikatti, Jaya Dwivedi, Chamanlal J. Shishoo & Kishor S. Jain. (2014) The chemistry and biological potential of azetidin-2-ones. European Journal of Medicinal Chemistry 74, pages 619-656.
Crossref
Crossref
Eric S. Orwoll & Elizabeth Martin. 2014. Osteogenesis Imperfecta. Osteogenesis Imperfecta
519
525
.
Suelem Demuner Ramalho, Aline Bernades, Giulio Demetrius, Caridad Noda‐Perez, Paulo Cezar Vieira, Caio Yu dos Santos, James Almada da Silva, Manoel Odorico de Moraes & Kristiana Cerqueira Mousinho. (2013) Synthetic Chalcone Derivatives as Inhibitors of Cathepsins K and B, and Their Cytotoxic Evaluation. Chemistry & Biodiversity 10:11, pages 1999-2006.
Crossref
Crossref
Michael R. McClung & Cristiano A. F. Zerbini. 2013. Osteoporosis. Osteoporosis
211
226
.
Jerald E. Dumas & Manu O. Platt. (2013) Systematic Optimization of Multiplex Zymography Protocol to Detect Active Cathepsins K, L, S, and V in Healthy and Diseased Tissue: Compromise Among Limits of Detection, Reduced Time, and Resources. Molecular Biotechnology 54:3, pages 1038-1047.
Crossref
Crossref
Manu Platt & Jerald Dumas. 2013. Tumor Angiogenesis Regulators. Tumor Angiogenesis Regulators
297
339
.
Cristina Vassalle & Giorgio Iervasi. (2013) Cathepsin K ? A classical bone biomarker in cardiovascular disease: The heart is not alone anymore. Atherosclerosis 228:1, pages 36-37.
Crossref
Crossref
M K Herroon, E Rajagurubandara, D L Rudy, A Chalasani, A L Hardaway & I Podgorski. (2012) Macrophage cathepsin K promotes prostate tumor progression in bone. Oncogene 32:12, pages 1580-1593.
Crossref
Crossref
Elena V. Tchetina, Natalia V. Demidova, Dmitry E. Karateev & Eugeny L. Nasonov. (2013)
Rheumatoid Factor Positivity Is Associated with Increased Joint Destruction and Upregulation of
Matrix Metalloproteinase 9
and
Cathepsin K
Gene Expression in the Peripheral Blood in Rheumatoid Arthritic Patients Treated with Methotrexate
. International Journal of Rheumatology 2013, pages 1-10.
Crossref
Crossref
Dieter Br?mme. 2013. Handbook of Proteolytic Enzymes. Handbook of Proteolytic Enzymes
1801
1807
.
Ulf H. Lerner. (2012) Osteoblasts, Osteoclasts, and Osteocytes: Unveiling Their Intimate-Associated Responses to Applied Orthodontic Forces. Seminars in Orthodontics 18:4, pages 237-248.
Crossref
Crossref
Lucie Brisson, Stephan J. Reshkin, Jacques Goré & Sébastien Roger. (2012) pH regulators in invadosomal functioning: Proton delivery for matrix tasting. European Journal of Cell Biology 91:11-12, pages 847-860.
Crossref
Crossref
Sara Sulpizio, Nicola Franceschini, Adriano Piattelli, Pierluigi Di Sebastiano, Paolo Innocenti & Federico Selvaggi. (2012) Cathepsins and pancreatic cancer: The 2012 update. Pancreatology 12:5, pages 395-401.
Crossref
Crossref
Mei-Shu Shih. (2012) Bone Adaptation in Osteoporosis. Current Osteoporosis Reports 10:3, pages 187-189.
Crossref
Crossref
Jos? Luis P?rez-Castrill?n, Florentino Pinacho, Marta Ruiz-Mambrilla & Antonio Due?as Laita. (2012) Odanacatib: a possible new therapeutic option for the treatment of osteoporosis. International Journal of Clinical Rheumatology 7:4, pages 369-376.
Crossref
Crossref
Zachary T. Barry & Manu O. Platt. (2012) Cathepsin S Cannibalism of Cathepsin K as a Mechanism to Reduce Type I Collagen Degradation. Journal of Biological Chemistry 287:33, pages 27723-27730.
Crossref
Crossref
Tadashi Hayami, Ya Zhuo, Gregg A. Wesolowski, Maureen Pickarski & Le T. Duong. (2012) Inhibition of cathepsin K reduces cartilage degeneration in the anterior cruciate ligament transection rabbit and murine models of osteoarthritis. Bone 50:6, pages 1250-1259.
Crossref
Crossref
Barbara Peruzzi & Anna Teti. (2011) The Physiology and Pathophysiology of the Osteoclast. Clinical Reviews in Bone and Mineral Metabolism 10:2, pages 71-97.
Crossref
Crossref
Le T Duong. (2012) Therapeutic inhibition of cathepsin K?reducing bone resorption while maintaining bone formation. BoneKEy Reports 1:5.
Crossref
Crossref
Nimali P. Withana, Galia Blum, Mansoureh Sameni, Clare Slaney, Arulselvi Anbalagan, Mary B. Olive, Bradley N. Bidwell, Laura Edgington, Ling Wang, Kamiar Moin, Bonnie F. Sloane, Robin L. Anderson, Matthew S. Bogyo & Belinda S. Parker. (2012) Cathepsin B Inhibition Limits Bone Metastasis in Breast Cancer. Cancer Research 72:5, pages 1199-1209.
Crossref
Crossref
Jerica Sabotič & Janko Kos. (2012) Microbial and fungal protease inhibitors—current and potential applications. Applied Microbiology and Biotechnology 93:4, pages 1351-1375.
Crossref
Crossref
Kostas Bougas, Ryo Jimbo, Ying Xue, Kamal Mustafa & Ann Wennerberg. (2012) Novel Implant Coating Agent Promotes Gene Expression of Osteogenic Markers in Rats during Early Osseointegration. International Journal of Biomaterials 2012, pages 1-9.
Crossref
Crossref
Keon-Young Park, Weiwei A. Li & Manu O. Platt. (2012) Patient specific proteolytic activity of monocyte-derived macrophages and osteoclasts predicted with temporal kinase activation states during differentiation. Integrative Biology 4:12, pages 1459.
Crossref
Crossref
Dongwei Zhang, Nelson Leung, Ekkehard Weber, Paul Saftig & Dieter Brömme. (2011) The effect of cathepsin K deficiency on airway development and TGF-β1 degradation. Respiratory Research 12:1.
Crossref
Crossref
Manuel Sosa & Esther Gonz?lez-Padilla. (2011) Promising developments in osteoporosis treatment. International Journal of Clinical Rheumatology 6:3, pages 325-332.
Crossref
Crossref
Justin Sturge, Matthew P. Caley & Jonathan Waxman. (2011) Bone metastasis in prostate cancer: emerging therapeutic strategies. Nature Reviews Clinical Oncology 8:6, pages 357-368.
Crossref
Crossref
Mariana Kasabova, Ahlame Saidi, Clément Naudin, Juliette Sage, Fabien Lecaille & Gilles Lalmanach. (2011) Cysteine Cathepsins: Markers and Therapy Targets in Lung Disorders. Clinical Reviews in Bone and Mineral Metabolism 9:2, pages 148-161.
Crossref
Crossref
S. Aubrey Stoch. 2011. Translational Medicine and Drug Discovery. Translational Medicine and Drug Discovery
115
167
.
Maria Arampatzidou, Kristina Mayer, Maria E. Iolyeva, Seblewongel Gebre Asrat, Mirunalini Ravichandran, Thomas Günther, Roland Schüle, Thomas Reinheckel & Klaudia Brix. (2011) Studies of intestinal morphology and cathepsin B expression in a transgenic mouse aiming at intestine-specific expression of Cath B-EGFP. Biological Chemistry 392:11.
Crossref
Crossref
Dieter Brömme & Susan Wilson. 2011. Extracellular Matrix Degradation. Extracellular Matrix Degradation
23
51
.
Benelita Tina Elie, Vasilena Gocheva, Tanaya Shree, Stacie A. Dalrymple, Leslie J. Holsinger & Johanna A. Joyce. (2010) Identification and pre-clinical testing of a reversible cathepsin protease inhibitor reveals anti-tumor efficacy in a pancreatic cancer model. Biochimie 92:11, pages 1618-1624.
Crossref
Crossref
Ernesto Canalis. (2010) New Treatment Modalities in Osteoporosis. Endocrine Practice 16:5, pages 855-863.
Crossref
Crossref
Jiaqiang Cai, Mark Baugh, Darcey Black, Clive Long, D. Jonathan Bennett, Maureen Dempster, Xavier Fradera, Jonathan Gillespie, Fiona Andrews, Sylviane Boucharens, John Bruin, Kenneth S. Cameron, Iain Cumming, William Hamilton, Philip S. Jones, Allard Kaptein, Emma Kinghorn, Maurice Maidment, Iain Martin, Ann Mitchell, Zoran Rankovic, John Robinson, Paul Scullion, Joost C.M. Uitdehaag, Paul Vink, Paul Westwood, Mario van Zeeland, Leon van Berkom, Martijn Bastiani & Tommi Meulemans. (2010) 6-Phenyl-1H-imidazo[4,5-c]pyridine-4-carbonitrile as cathepsin S inhibitors. Bioorganic & Medicinal Chemistry Letters 20:15, pages 4350-4354.
Crossref
Crossref
Jiaqiang Cai, D. Jonathan Bennett, Zoran Rankovic, Maureen Dempster, Xavier Fradera, Jonathan Gillespie, Iain Cumming, William Finlay, Mark Baugh, Sylviane Boucharens, John Bruin, Kenneth S. Cameron, William Hamilton, Jennifer Kerr, Emma Kinghorn, George McGarry, John Robinson, Paul Scullion, Joost C.M. Uitdehaag, Mario van Zeeland, Dominique Potin, Laurent Saniere, Andre Fouquet, Francois Chevallier, Hortense Deronzier, Cecile Dorleans & Eric Nicolai. (2010) 2-Phenyl-9H-purine-6-carbonitrile derivatives as selective cathepsin S inhibitors. Bioorganic & Medicinal Chemistry Letters 20:15, pages 4447-4450.
Crossref
Crossref
Jiaqiang Cai, Xavier Fradera, Mario van Zeeland, Maureen Dempster, Kenneth S. Cameron, D. Jonathan Bennett, John Robinson, Lucy Popplestone, Mark Baugh, Paul Westwood, John Bruin, William Hamilton, Emma Kinghorn, Clive Long & Joost C.M. Uitdehaag. (2010) 4-(3-Trifluoromethylphenyl)-pyrimidine-2-carbonitrile as cathepsin S inhibitors: N3, not N1 is critically important. Bioorganic & Medicinal Chemistry Letters 20:15, pages 4507-4510.
Crossref
Crossref
Andriy O Samokhin, Paul Ambrose Lythgo, Jacques Yves Gauthier, M David Percival & Dieter Brömme. (2010) Pharmacological Inhibition of Cathepsin S Decreases Atherosclerotic Lesions in Apoe-/- Mice. Journal of Cardiovascular Pharmacology 56:1, pages 98-105.
Crossref
Crossref
John G. Allen, Christopher Fotsch & Philip Babij. (2010) Emerging Targets in Osteoporosis Disease Modification. Journal of Medicinal Chemistry 53:11, pages 4332-4353.
Crossref
Crossref
Gaetano Leto, Maria Vittoria Sepporta, Marilena Crescimanno, Carla Flandina & Francesca Maria Tumminello. (2010) Cathepsin L in metastatic bone disease: therapeutic implications. Biological Chemistry 391:6.
Crossref
Crossref
Elise Isabel, Kevin P. Bateman, Nathalie Chauret, Wanda Cromlish, Sylvie Desmarais, Le T. Duong, Jean-Pierre Falgueyret, Jacques Yves Gauthier, Sonia Lamontagne, Cheuk K. Lau, Serge L?ger, Tammy LeRiche, Jean-Fran?ois L?vesque, Chun Sing Li, Fr?d?ric Mass?Daniel J. McKay, Christophe Mellon, Deborah A. Nicoll-Griffith, Renata M. Oballa, M. David Percival, Denis Riendeau, Jo?l Robichaud, Gideon A. Rodan, Sevgi B. Rodan, Carmai Seto, Michel Th?rien, Vouy Linh Truong, Gregg Wesolowski, Robert N. Young, Robert Zamboni & W. Cameron Black. (2010) The discovery of MK-0674, an orally bioavailable cathepsin K inhibitor. Bioorganic & Medicinal Chemistry Letters 20:3, pages 887-892.
Crossref
Crossref
Jos? Luis P?rez-Castrill?n, Florentino Pinacho, Daniel De Luis, Mar?a Lopez-Menendez & Antonio Due?as Laita. (2010) Odanacatib, a New Drug for the Treatment of Osteoporosis: Review of the Results in Postmenopausal Women. Journal of Osteoporosis 2010, pages 1-5.
Crossref
Crossref
Toshiyuki Yoneda. (2010) Targeted therapeutic interventions for cancers colonized in bone. Drug Delivery System 25:2, pages 110-119.
Crossref
Crossref
Jae-Suk Chang. (2010) Osteoporotic Fracture-Medical Treatment. Journal of the Korean Fracture Society 23:3, pages 326.
Crossref
Crossref
Yihe Jia, Ke Wang, Huifang Wang, Botao Zhang, Kan Yang, Zhilan Zhang, Haijuan Dong & Jinxin Wang. (2022) Discovery of Selective Covalent Cathepsin K Inhibitors Containing Novel 4-Cyanopyrimidine Warhead Based on Quantum Chemical Calculations and Binding Mode Analysis. SSRN Electronic Journal.
Crossref
Crossref